Pulmo Pharma
Hingham
About Pulmo Pharma
Pulmo Pharma was founded by graduates of the University of Technology Sydney (Australia), University of Rhode Island (USA), TU Munich (Germany), KU Leuven (Belgium), University of Tokyo (Japan), University of Tartu (Estonia), University of Oulu (Finland) and the University of Leicester (UK). We research pulmonary diseases & develop new therapies for patients suffering from hereditary and toxin caused lung diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $55.0M
- Funding stage: Private Equity
- Last round: Private Equity (Jun 2017)
- Website: pulmo-pharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Canonical: https://fsome.com/organization/pulmo-pharma-189083 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.